Breaking News! Another #IDHinhibitor receives #FDAapproval for IDH1-mutated #AML https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-olutasidenib-relapsed-or-refractory-acute-myeloid-leukemia-susceptible-idh1-mutation?sf173413269=1
#idhinhibitor #fdaapproval #aml